Correspondence to Jacob Allan Udell, Cardiovascular Division, Department of Medicine, Women’s College Hospital, Women’s College Research Institute, University of Toronto, Toronto ON M5S 1B1, Canada; ...

Background and aims In the primary prevention setting, low-dose aspirin reduces major vascular events (MVEs) by approximately ...

Background Menopause is a timely opportunity to screen for cardiovascular disease (CVD) and intervene with healthier ...

Background There is substantial interest in the cardiovascular effects of e-cigarette use, highlighting the need to update ...

Determining kidney function-specific thresholds for N-terminal pro-B-type natriuretic peptide in heart failure risk prediction among patients with chronic kidney disease: a multicentre, observational, ...

St George's Hospital Medical School, Histopathology Department, London, UK Professor M J Davies, St George's Hospital Medical School, Histopathology Department, Cranmer Terrace, London SW17 0RE, UK If ...

Professor Freek W A Verheugt, Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Oosterpark 9, NL-1091-AC Amsterdam, Netherlands; f.w.a.verheugt{at}olvg.nl If you wish to reuse any or all of this ...

Dr Bernard Iung, Cardiology Department, Bichat Hospital, 46, rue Henri Huchard, 75018 Paris, France email: bernard.iung{at}bch.ap-hop-paris.fr If you wish to reuse ...

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...

Background Intravenous iron therapy with ferric derisomaltose (FDI) has been shown to improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency.

Heightened interest in left ventricular thrombus (LVT) stems from the consistent association of subsequent stroke and systemic embolism after LVT, and many aspects of its management still exist in a ...